Low or minimal expression of CEACAM1 on tumor infiltrating T cells suggests that the primary function of CEACAM1 in vivo is mediated via cells other than CD8+ T cells, and the potential role of CEACAM1 in immuno-oncology remains to be established. The gene discussed is CD8A; the disease is neoplasm.